Regulation of Twist in the metastasis of non-small cell lung cancer by miR-92b

被引:1
|
作者
Liu, X. [1 ]
Tian, X. -D. [1 ]
Liu, Y. [1 ]
Zhang, T. [1 ]
Chen, L. [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Thorac Surg, Beijing, Peoples R China
基金
北京市自然科学基金;
关键词
Non-small cell lung cancer (NSCLC); Twist; miR-92b; BREAST-CANCER; MESENCHYMAL TRANSITION; NSCLC; EXPRESSION; PROLIFERATION; INHIBITION; RESISTANCE; CARCINOMA; INVASION; GROWTH;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: It is well documented that some microRNAs (miRNAs) regulates tumorigenesis and cancer metastases of non-small cell lung cancer (NSCLC). Nevertheless, a role of miR-92b in control of the metastasis of NSCLC has not been acknowledged. MATERIALS AND METHODS: Here, we reported that miR-92b levels were significantly decreased and Twist levels were significantly increased in NSCLC specimens, compared to paired adjacent non-tumor lung tissue. Moreover, the levels of miR-92b and Twist inversely correlated. RESULTS: Bioinformatics analyses and luciferase-reporter assay showed that miR-92b targeted the 3'-UTR of Twist mRNA to inhibit its translation. Overexpression of miR-92b inhibited Twist-mediated cell invasiveness, while depletion of miR-92b increased Twist-mediated cell invasiveness in either a transwell cell migration assay or a scratch wound healing assay. CONCLUSIONS: Together, our data suggest that re-expression of miR-92b may inhibit Twist-mediated NSCLC metastasis.
引用
收藏
页码:4003 / 4010
页数:8
相关论文
共 50 条
  • [1] Circulating miR-92b and miR-375 for monitoring the chemoresistance and prognosis of small cell lung cancer
    Ming Li
    Wulin Shan
    Bo Hong
    Jinglu Zou
    Hong Li
    Dandan Han
    Yang Zhang
    Lailing Li
    Dan Li
    Wenchu Lin
    Scientific Reports, 10
  • [2] Circulating miR-92b and miR-375 for monitoring the chemoresistance and prognosis of small cell lung cancer
    Li, Ming
    Shan, Wulin
    Hong, Bo
    Zou, Jinglu
    Li, Hong
    Han, Dandan
    Zhang, Yang
    Li, Lailing
    Li, Dan
    Lin, Wenchu
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [3] Circulating miR-92b and miR-375 for monitoring chemoresistance and prognosis of patients with small cell lung cancer
    Ming, L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 281 - 282
  • [4] MiR-92b regulates the cell growth, cisplatin chemosensitivity of A549 non small cell lung cancer cell line and target PTEN
    Li, Yan
    Li, Li
    Guan, Yan
    Liu, Xiuju
    Meng, Qingyong
    Guo, Qisen
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 440 (04) : 604 - 610
  • [5] Integrin α6 promotes esophageal cancer metastasis and is targeted by miR-92b
    Ma, Gang
    Jing, Chao
    Huang, Furong
    Li, Xukun
    Cao, Xiufeng
    Liu, Zhihua
    ONCOTARGET, 2017, 8 (04) : 6681 - 6690
  • [6] Spatiotemporal regulation of myocardin is essential for non-small cell lung cancer metastasis
    Yang, Haixia
    Yang, Guihua
    Li, Hong
    Liu, Rui
    Zhao, Hengqiang
    Wei, Ze
    Wu, Tina
    Zheng, Hui
    Zheng, Zhifa
    Yu, Zhe
    Wang, Aijun
    Su, Jianzhong
    Yang, Changhong
    Wu, Zhihong
    ADVANCES IN CANCER BIOLOGY-METASTASIS, 2022, 6
  • [7] Overexpression of miR-1260b in Non-small Cell Lung Cancer is Associated with Lymph Node Metastasis
    Xu, Limin
    Li, Liqin
    Li, Jing
    Li, Hongwei
    Shen, Qibin
    Ping, Jinliang
    Ma, Zhihong
    Zhong, Jing
    Dai, Licheng
    AGING AND DISEASE, 2015, 6 (06): : 478 - 485
  • [8] Gallbladder metastasis of non-small cell lung cancer
    Nassenstein, K
    Kissler, M
    ONKOLOGIE, 2004, 27 (04): : 398 - 400
  • [9] Perianal Metastasis of Non-Small Cell Lung Cancer
    Imai, Hisao
    Inafuku, Kenji
    Wakuda, Kazushige
    Ono, Akira
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Watanabe, Reiko
    Naito, Tateaki
    Murakami, Haruyasu
    Ito, Ichiro
    Endo, Masahiro
    Tanabe, Hiroyasu
    Nakajima, Takashi
    Takahashi, Toshiaki
    INTERNAL MEDICINE, 2014, 53 (11) : 1149 - 1152
  • [10] Role of miR-520b in non-small cell lung cancer
    Zhang, Linlin
    Yu, Shuangquan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (05) : 3987 - 3995